HEADER CHAPERONE 15-OCT-09 3K98 TITLE HSP90 N-TERMINAL DOMAIN IN COMPLEX WITH (1R)-2-(5-CHLORO-2,4- TITLE 2 DIHYDROXYBENZOYL)-N-ETHYLISOINDOLINE-1-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HSP90 N-TERMINAL DOMAIN (UNP RESIDUES 9-225); COMPND 5 SYNONYM: HSP 86, RENAL CARCINOMA ANTIGEN NY-REN-38; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSP90AA1, HSP90A, HSPC1, HSPCA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HSP90, ATP BINDING DOMAIN, INHIBITION, ACETYLATION, ALTERNATIVE KEYWDS 2 SPLICING, ATP-BINDING, CHAPERONE, CYTOPLASM, NUCLEOTIDE-BINDING, KEYWDS 3 PHOSPHOPROTEIN, STRESS RESPONSE EXPDTA X-RAY DIFFRACTION AUTHOR K.S.GAJIWALA,J.F.DAVIES II REVDAT 3 21-FEB-24 3K98 1 REMARK SEQADV REVDAT 2 01-NOV-17 3K98 1 REMARK REVDAT 1 09-FEB-10 3K98 0 JRNL AUTH P.P.KUNG,B.HUANG,G.ZHANG,J.Z.ZHOU,J.WANG,J.A.DIGITS, JRNL AUTH 2 J.SKAPTASON,S.YAMAZAKI,D.NEUL,M.ZIENTEK,J.ELLERAAS,P.MEHTA, JRNL AUTH 3 M.J.YIN,M.J.HICKEY,K.S.GAJIWALA,C.RODGERS,J.F.DAVIES, JRNL AUTH 4 M.R.GEHRING JRNL TITL DIHYDROXYPHENYLISOINDOLINE AMIDES AS ORALLY BIOAVAILABLE JRNL TITL 2 INHIBITORS OF THE HEAT SHOCK PROTEIN 90 (HSP90) MOLECULAR JRNL TITL 3 CHAPERONE. JRNL REF J.MED.CHEM. V. 53 499 2010 JRNL REFN ISSN 0022-2623 JRNL PMID 19908836 JRNL DOI 10.1021/JM901209Q REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 223449.290 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 31733 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1615 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2560 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2580 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1683 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0060 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 32952 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4765 REMARK 3 BIN R VALUE (WORKING SET) : 0.2330 REMARK 3 BIN FREE R VALUE : 0.2720 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 255 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3452 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 55 REMARK 3 SOLVENT ATOMS : 132 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.21000 REMARK 3 B22 (A**2) : -6.36000 REMARK 3 B33 (A**2) : 3.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.24 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.600 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.380 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.270 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.050 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.020 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 31.66 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.P REMARK 3 PARAMETER FILE 3 : WATER_REP.PAR REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIG.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : LIG.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3K98 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-OCT-09. REMARK 100 THE DEPOSITION ID IS D_1000055705. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-OCT-05 REMARK 200 TEMPERATURE (KELVIN) : 98 REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-D REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17618 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.11300 REMARK 200 R SYM (I) : 0.11300 REMARK 200 FOR THE DATA SET : 18.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.43100 REMARK 200 R SYM FOR SHELL (I) : 0.43100 REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16 % EHTYLENE GLYCOL, 0.1 M PHOSPHATE REMARK 280 -CITRATE, PH 4.2, 30 MM TCEP, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.99300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.04550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.02600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.04550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.99300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.02600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -45.98600 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 8 REMARK 465 LEU A 122 REMARK 465 GLN A 123 REMARK 465 ALA A 124 REMARK 465 GLY A 125 REMARK 465 HIS A 228 REMARK 465 HIS A 229 REMARK 465 HIS A 230 REMARK 465 HIS A 231 REMARK 465 HIS A 232 REMARK 465 HIS A 233 REMARK 465 HIS A 234 REMARK 465 HIS A 235 REMARK 465 HIS A 236 REMARK 465 HIS A 237 REMARK 465 HIS A 238 REMARK 465 HIS A 239 REMARK 465 MET B 8 REMARK 465 HIS B 230 REMARK 465 HIS B 231 REMARK 465 HIS B 232 REMARK 465 HIS B 233 REMARK 465 HIS B 234 REMARK 465 HIS B 235 REMARK 465 HIS B 236 REMARK 465 HIS B 237 REMARK 465 HIS B 238 REMARK 465 HIS B 239 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 40 59.96 -103.43 REMARK 500 THR A 94 38.23 -99.64 REMARK 500 ASN B 40 55.25 -114.66 REMARK 500 HIS B 228 -23.88 75.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1RC A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1RC B 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3K97 RELATED DB: PDB REMARK 900 RELATED ID: 3K99 RELATED DB: PDB DBREF 3K98 A 9 225 UNP P07900 HS90A_HUMAN 9 225 DBREF 3K98 B 9 225 UNP P07900 HS90A_HUMAN 9 225 SEQADV 3K98 MET A 8 UNP P07900 INITIATING METHIONINE SEQADV 3K98 LEU A 226 UNP P07900 EXPRESSION TAG SEQADV 3K98 GLU A 227 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 228 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 229 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 230 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 231 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 232 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 233 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 234 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 235 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 236 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 237 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 238 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS A 239 UNP P07900 EXPRESSION TAG SEQADV 3K98 MET B 8 UNP P07900 INITIATING METHIONINE SEQADV 3K98 LEU B 226 UNP P07900 EXPRESSION TAG SEQADV 3K98 GLU B 227 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 228 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 229 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 230 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 231 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 232 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 233 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 234 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 235 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 236 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 237 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 238 UNP P07900 EXPRESSION TAG SEQADV 3K98 HIS B 239 UNP P07900 EXPRESSION TAG SEQRES 1 A 232 MET ASP GLN PRO MET GLU GLU GLU GLU VAL GLU THR PHE SEQRES 2 A 232 ALA PHE GLN ALA GLU ILE ALA GLN LEU MET SER LEU ILE SEQRES 3 A 232 ILE ASN THR PHE TYR SER ASN LYS GLU ILE PHE LEU ARG SEQRES 4 A 232 GLU LEU ILE SER ASN SER SER ASP ALA LEU ASP LYS ILE SEQRES 5 A 232 ARG TYR GLU SER LEU THR ASP PRO SER LYS LEU ASP SER SEQRES 6 A 232 GLY LYS GLU LEU HIS ILE ASN LEU ILE PRO ASN LYS GLN SEQRES 7 A 232 ASP ARG THR LEU THR ILE VAL ASP THR GLY ILE GLY MET SEQRES 8 A 232 THR LYS ALA ASP LEU ILE ASN ASN LEU GLY THR ILE ALA SEQRES 9 A 232 LYS SER GLY THR LYS ALA PHE MET GLU ALA LEU GLN ALA SEQRES 10 A 232 GLY ALA ASP ILE SER MET ILE GLY GLN PHE GLY VAL GLY SEQRES 11 A 232 PHE TYR SER ALA TYR LEU VAL ALA GLU LYS VAL THR VAL SEQRES 12 A 232 ILE THR LYS HIS ASN ASP ASP GLU GLN TYR ALA TRP GLU SEQRES 13 A 232 SER SER ALA GLY GLY SER PHE THR VAL ARG THR ASP THR SEQRES 14 A 232 GLY GLU PRO MET GLY ARG GLY THR LYS VAL ILE LEU HIS SEQRES 15 A 232 LEU LYS GLU ASP GLN THR GLU TYR LEU GLU GLU ARG ARG SEQRES 16 A 232 ILE LYS GLU ILE VAL LYS LYS HIS SER GLN PHE ILE GLY SEQRES 17 A 232 TYR PRO ILE THR LEU PHE VAL GLU LYS GLU LEU GLU HIS SEQRES 18 A 232 HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS SEQRES 1 B 232 MET ASP GLN PRO MET GLU GLU GLU GLU VAL GLU THR PHE SEQRES 2 B 232 ALA PHE GLN ALA GLU ILE ALA GLN LEU MET SER LEU ILE SEQRES 3 B 232 ILE ASN THR PHE TYR SER ASN LYS GLU ILE PHE LEU ARG SEQRES 4 B 232 GLU LEU ILE SER ASN SER SER ASP ALA LEU ASP LYS ILE SEQRES 5 B 232 ARG TYR GLU SER LEU THR ASP PRO SER LYS LEU ASP SER SEQRES 6 B 232 GLY LYS GLU LEU HIS ILE ASN LEU ILE PRO ASN LYS GLN SEQRES 7 B 232 ASP ARG THR LEU THR ILE VAL ASP THR GLY ILE GLY MET SEQRES 8 B 232 THR LYS ALA ASP LEU ILE ASN ASN LEU GLY THR ILE ALA SEQRES 9 B 232 LYS SER GLY THR LYS ALA PHE MET GLU ALA LEU GLN ALA SEQRES 10 B 232 GLY ALA ASP ILE SER MET ILE GLY GLN PHE GLY VAL GLY SEQRES 11 B 232 PHE TYR SER ALA TYR LEU VAL ALA GLU LYS VAL THR VAL SEQRES 12 B 232 ILE THR LYS HIS ASN ASP ASP GLU GLN TYR ALA TRP GLU SEQRES 13 B 232 SER SER ALA GLY GLY SER PHE THR VAL ARG THR ASP THR SEQRES 14 B 232 GLY GLU PRO MET GLY ARG GLY THR LYS VAL ILE LEU HIS SEQRES 15 B 232 LEU LYS GLU ASP GLN THR GLU TYR LEU GLU GLU ARG ARG SEQRES 16 B 232 ILE LYS GLU ILE VAL LYS LYS HIS SER GLN PHE ILE GLY SEQRES 17 B 232 TYR PRO ILE THR LEU PHE VAL GLU LYS GLU LEU GLU HIS SEQRES 18 B 232 HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS HET 1RC A 901 25 HET PO4 A 902 5 HET 1RC B 901 25 HETNAM 1RC (1R)-2-[(5-CHLORO-2,4-DIHYDROXYPHENYL)CARBONYL]-N- HETNAM 2 1RC ETHYL-2,3-DIHYDRO-1H-ISOINDOLE-1-CARBOXAMIDE HETNAM PO4 PHOSPHATE ION HETSYN 1RC (1R)-2-(5-CHLORO-2,4-DIHYDROXYBENZOYL)-N- HETSYN 2 1RC ETHYLISOINDOLINE-1-CARBOXAMIDE FORMUL 3 1RC 2(C18 H17 CL N2 O4) FORMUL 4 PO4 O4 P 3- FORMUL 6 HOH *132(H2 O) HELIX 1 1 GLN A 23 THR A 36 1 14 HELIX 2 2 GLU A 42 ASP A 66 1 25 HELIX 3 3 PRO A 67 ASP A 71 5 5 HELIX 4 4 THR A 99 LEU A 107 1 9 HELIX 5 5 SER A 113 ALA A 121 1 9 HELIX 6 6 ASP A 127 GLN A 133 5 7 HELIX 7 7 VAL A 136 LEU A 143 5 8 HELIX 8 8 GLN A 194 LEU A 198 5 5 HELIX 9 9 GLU A 199 SER A 211 1 13 HELIX 10 10 GLN B 23 THR B 36 1 14 HELIX 11 11 GLU B 42 ASP B 66 1 25 HELIX 12 12 PRO B 67 GLY B 73 5 7 HELIX 13 13 THR B 99 LEU B 107 1 9 HELIX 14 14 THR B 115 GLY B 125 1 11 HELIX 15 15 ASP B 127 GLY B 135 5 9 HELIX 16 16 VAL B 136 LEU B 143 5 8 HELIX 17 17 GLU B 192 LEU B 198 5 7 HELIX 18 18 GLU B 199 SER B 211 1 13 SHEET 1 A16 VAL A 17 ALA A 21 0 SHEET 2 A16 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 A16 GLN A 159 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 A16 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162 SHEET 5 A16 GLY A 183 LEU A 190 -1 O ILE A 187 N THR A 149 SHEET 6 A16 THR A 88 ASP A 93 -1 N ILE A 91 O VAL A 186 SHEET 7 A16 ILE A 78 ASN A 83 -1 N ASN A 79 O VAL A 92 SHEET 8 A16 ILE A 218 GLU A 225 1 O PHE A 221 N LEU A 80 SHEET 9 A16 ILE B 218 GLU B 225 -1 O LEU B 220 N LYS A 224 SHEET 10 A16 ILE B 78 ASN B 83 1 N LEU B 80 O THR B 219 SHEET 11 A16 THR B 88 ASP B 93 -1 O VAL B 92 N ASN B 79 SHEET 12 A16 GLY B 183 LEU B 190 -1 O VAL B 186 N ILE B 91 SHEET 13 A16 ALA B 145 LYS B 153 -1 N ILE B 151 O LYS B 185 SHEET 14 A16 GLN B 159 SER B 164 -1 O TRP B 162 N VAL B 150 SHEET 15 A16 SER B 169 THR B 174 -1 O ARG B 173 N ALA B 161 SHEET 16 A16 GLU B 18 ALA B 21 -1 N PHE B 20 O PHE B 170 SITE 1 AC1 13 LEU A 48 ASN A 51 ALA A 55 LYS A 58 SITE 2 AC1 13 ASP A 93 ILE A 96 GLY A 97 MET A 98 SITE 3 AC1 13 PHE A 138 THR A 184 VAL A 186 HOH A 241 SITE 4 AC1 13 HOH A 254 SITE 1 AC2 5 GLU A 199 GLU A 200 ARG A 201 HIS B 154 SITE 2 AC2 5 ASN B 155 SITE 1 AC3 13 HOH B 5 HOH B 6 ASN B 51 SER B 52 SITE 2 AC3 13 ASP B 54 ALA B 55 LYS B 58 ASP B 93 SITE 3 AC3 13 ILE B 96 MET B 98 PHE B 138 THR B 184 SITE 4 AC3 13 VAL B 186 CRYST1 45.986 80.052 118.091 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021746 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012492 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008468 0.00000